Funds will support development of research grant applications for potential future funding programs related to COVID-19 as well as small-scale, time-sensitive research projects. “Congratulations to the recipients of the $2.9 million in research funding to support Ontario’s response to COVID-19,” said Ross Romano, minister of colleges and universities. Noting that the team brings together experts in viral immunology, virology and pathology, Bridle said the group responded rapidly to the provincial government’s call for research proposals. The team will work with Health Canada to ensure “fast tracking” for any potential vaccine to be released to the public. The Ontario government is investing over $2.9 million to fund eight research projects that will help support Ontario’s response to COVID-19. New Ontario Funding for COVID-19 research The following funding opportunity requires quick action. “We want to secure proposals that have a high chance of success and can do so in a very quick fashion.”, “We want to find a vaccine at the soonest possible opportunity, like all of you - that is our priority.”. The technology uses a proven testing platform of viruses already used to develop cancer vaccines. “This money will be dedicated towards receiving proposals,” he said. “You deserve to hear from the same experts and get the same information that I have as premier.”, “On Monday, you will see how far we’ve come, how far we still have to go. Help stop the spread. The projects are among eight new initiatives that were funded at universities and health-care centres across Ontario, with a total government investment of $2.9 million. As part of the Ontario Research Fund – 2015 Large Infrastructure application process, institutions submit Notices of Intent to the program. Health Sciences has a wide variety of programs at the Undergraduate, Graduate and Post-Graduate Levels. “We can rapidly apply cancer technology and move it over to infectious disease.”. The team has also received support from the Department of Pathobiology, the Ontario Veterinary College and the University’s COVID-19 Research Development and Catalyst Fund. Ontario Genomics; Ontario Research Fund (ORF) and Early Researcher Award (ERA) ... Award holders will need to attest that their research was disrupted by COVID-19 constraints and that they are not benefiting from compensation under the Canada Emergency Student Benefit or the Canada Emergency Response Benefit or other income supports related to COVID-19. Thursday, May 21, 2020Friday, June 19, 2020. For any virus that does get past the body’s defences, they will also monitor production of T cells that normally fight off infection. firstname.lastname@example.org, Angela Mulholland, ; The proposal should clearly define the research milestones and the corresponding budget required to achieve each milestone. Please note that there are specific application forms for the respective COVID19RF categories. “We are going to base this on health. Their approach illuminates where the lung receives fresh air, where this is blocked and where aerated blood flows and where it is stopped. Tina Depko, McMaster researchers receive provincial support for COVID-19 research, Health Research Methods, Evidence and Impact, Centre for Simulation-based Learning (CSBL), Foundation for Medical Practice Education, Gender and Health Education Initiative Program, Indigenous Students Health Sciences Office (ISHS), McMaster Education Research, Innovation and Theory, Professionalism in Clinically Based Education, Program for Interprofessional Education, Practice and Research (PIPER). Can an air purifier kill COVID-19 in your home? Following immunological and safety testing at U of G, the researchers expect to share their top two vaccine candidates in about eight months with collaborators led by Darwyn Kobasa, head of respiratory virus pathogenesis and therapeutics at the National Microbiology Laboratory (NML) in Winnipeg, for efficacy testing. The Ontario COVID-19 Rapid Research Fund provides colleges, universities, research institutes and academic hospitals with funding to contribute to global efforts to contain the COVID-19 pandemic. Application Submission. It could be a target protein in a cancer cell, but it could just as easily be a protein on a virus.”, “I would like to congratulate Byram Bridle and the whole team at the University of Guelph on receiving this project approval through the COVID-19 Rapid Research Fund,” said Kitchener-Conestoga MPP Mike Harris. The world needs a vaccine and there’s no reason we can’t develop one right here in Ontario. He said that unlike other “one-off” approaches to developing a COVID-19 vaccine, the team’s platforms can be adapted to develop vaccines for future versions of a coronavirus. In doing so, our government’s intelligent investment will ensure that this University of Guelph research will address the challenges of this pandemic, as well as any coronavirus diseases that may emerge in the future.”. “We can rapidly apply cancer technology and move it over to infectious disease.”. neighbourhood launches their own 'Little Free Pantry'. There’s nothing we can’t do.”. Researchers are now also beginning to understand the long-term effects of the disease on the lungs and believe it may cause irreversible lung damage and debilitating symptoms. The team received a total of $876,000 over two years to complete the study. McMaster’s Faculty of Health Sciences has a global reputation for innovation and excellence in education. 519-824-4120, Ext. 2015 Large Infrastructure Notices of Intent. Bridle, Wootton and Susta have collaborated on using viruses in cancer therapy, including one of the viruses that they are now testing for a possible coronavirus vaccine. Comprehensive directory of all Western social media, Western University1151 Richmond Street Other approaches using a killed virus may be developed more quickly, he said, but many of those vaccines will fail to trigger the body’s proper immune response. That means future vaccines might be made more quickly and cheaply, giving Canada a foundation for subsequent vaccine development. “We have a strong history of working on developing cancer vaccines. “We have been focused on cancer for years, but this collaboration shows the flexibility of the technology we have at Guelph,” he said. They plan to look for levels of specific antibodies that recognize the protein and prevent the virus from entering lung cells. While acknowledging that Ontarians are eager to return to normal, Ford said that cannot be a reality until a vaccine is discovered. The researchers hope to also provide insight into whether or not patients with chronic lung diseases like asthma and COPD need different strategies to improve outcomes. A team of researchers across Ontario led by Schulich School of Medicine & Dentistry professor Grace Parraga has received new funding from the Ontario COVID-19 Rapid Research Fund. University of Guelph researchers have received $230,000 to develop potential COVID-19 vaccines under the province’s Ontario Together investment to advance research to combat the pandemic. Police searching for transport truck following fatal hit-and-run in Vaughan, Ont. Overall, the province has committed $20 million through its COVID-19 Rapid Research Fund – part of the Ontario Together fund — for research to help combat the pandemic. Ford went on to state that the province will only move forward once “the green light” is given by health officials. Projects were evaluated by a peer review committee to ensure that the province leveraged the expertise of researchers to evaluate and fund the most promising and important projects. Curated list of open funding calls and grants for researchers, non-profit organizations and commercial organizations, specifically for COVID-19 and coronavirus-related research and treatment The team, which includes co-investigators and collaborators from the Hospital for Sick Children, Lakehead University, McMaster University and Ryerson University, expect to provide an understanding about the lung abnormalities that persist in COVID-19 patients post-infection and how they influence quality of life, recovery time, health care planning and treatment. Manager, News Service By using live vectors to deliver the vaccine directly into cells, he said, the approach ensures an appropriate immune response. From: Innovation, Science and Economic Development Canada. Sell medical supplies, find personal protective equipment (PPE), solve problems, or volunteer to help protect against COVID-19. Kathy Georgiades, associate professor of psychiatry and behavioural neurosciences and a researcher with the Offord Centre for Child Studies, has received funding from the Province to study the impact of COVID-19 on the mental health and well-being of children and their families. 519-824-4120, Ext. After ferrying the protein into mice using a common adenovirus and an avian virus that normally infects chickens, they will measure immune responses in two ways. Researchers at the University of Guelph’s Ontario Veterinary College have received $230,000 to develop potential COVID-19 vaccines under the province’s Ontario Together investment to advance research to combat the pandemic.